Psoriasis   

SLE manifestations include arthralgias and cytopenias which are stable. Previously did well on methotrexate, but developed GI side effects. HCQ is on ...

The patient has ongoing inflammatory arthritis despite methotrexate, apremilast, and jak inhibitor trials.

Do you start/trial them on another biologic or just rely on topical therapies?

Do you use combination therapies such as betamethasone and calcipotriene foam?

If so, how long? 

Do you first try adding topicals or UV? At what point do you decide to switch biologics and at that point do you try to class switch to a different MO...

What side effects do you highlight in conversation with them? How do you approach toxicity monitoring?

Are there patients that you find respond best to these therapies?

Mother's insurance plan has a high deductible and phototherapy is inconvenient (family lives 50 minutes away). 

I have an elderly patient with a history of biopsy-proven psoriasis on IL-17 biologic therapy. She has developed an intense itch without a primary ras...

With no high-risk exposure do you repeat quant gold?

Are there any medications that surgeons like discontinued before their procedure?

Do you prefer restarting the biologic with the loading or maintenance dosing?

In other words, do we think of TNFi induced lupus and TNFi induced psoriasis as a drug effect or a class effect? 

In patients refractory to NSAIDs and sulfasalazine